In a new clinical study, researchers from the Texas Biomedical Device Center (TxBDC) at The University of Texas at Dallas demonstrated unprecedented rates of recovery for spinal cord injuries. This approach, called closed-loop vagus nerve stimulation (CLV), produced meaningful improvements in arm and hand function in these individuals. “This study is different: Therapy alone for spinal cord injury didn’t help our participants at all. A Phase 3 pivotal trial will include 70 participants at multiple U.S. institutions that specialize in spinal cord injury. Kilgard has a financial interest in MicroTransponder Inc., which markets vagus nerve stimulation therapy for stroke.